Rheolytic thrombectomy before direct stenting did not meet primary efficacy endpoints but reduced 6-month MACE vs direct stenting alone (11.2% vs 19.4%; p=0.011).
RCT (n=501)
randomly allocated
Yes
Absolute Event Rate: 85.8% vs 78.8%
p-value: p=0.043
OBJECTIVES: The aim of this study was to determine whether rheolytic thrombectomy (RT) before direct infarct artery stenting as compared with direct stenting (DS) alone results in improved myocardial reperfusion and clinical outcome in patients with acute myocardial infarction. BACKGROUND: The routine removal of thrombus before infarct artery stenting is still a matter of debate. METHODS: This is a multicenter, international, randomized, 2-arm, prospective study. Eligible patients were patients with acute myocardial infarction, angiographic evidence of thrombus grade 3 to 5, and a reference vessel diameter ≥2.5 mm. Coprimary end points were early ST-segment resolution and (99m)Tc-sestamibi infarct size. An α value = 0.05 achieved by both coprimary surrogate end points or an α value = 0.025 for a single primary surrogate end point would be considered evidence of statistical significance. Other surrogate end points were Thrombolysis In Myocardial Infarction (TIMI) flow grade 3, corrected TIMI frame count, and TIMI grade 3 blush. Clinical end points were a composite of major adverse cardiovascular events at 1, 6, and 12 months. RESULTS: From December 2005 to September 2009, 501 patients were randomly allocated to RT before DS or to DS alone. The ST-segment resolution was more frequent in the RT arm as compared with the DS alone arm: 85.8% and 78.8%, respectively (p = 0.043), while no difference between groups were revealed in the other surrogate end points. The 6-month major adverse cardiovascular events rate was 11.2% in the thrombectomy arm and 19.4% in the DS alone arm (p = 0.011). The 1-year event-free survival rates were 85.2 ± 2.3% for the RT arm, and 75.0 ± 3.1% for the DS alone arm (p = 0.009). CONCLUSIONS: Although the primary efficacy end points were not met, the results of this study support the use of RT before infarct artery stenting in patients with acute myocardial infarction and evidence of coronary thrombus. (AngioJet Rheolytic Thrombectomy Before Direct Infarct Artery Stenting in Patients Undergoing Primary PCI for Acute Myocardial Infarction JETSTENT; NCT00275990).
Migliorini et al. (Fri,) conducted a rct in acute myocardial infarction (n=501). rheolytic thrombectomy (RT) before direct infarct artery stenting vs. direct stenting (DS) alone was evaluated on early ST-segment resolution and (99m)Tc-sestamibi infarct size (p=0.043). Rheolytic thrombectomy before direct stenting did not meet primary efficacy endpoints but reduced 6-month MACE vs direct stenting alone (11.2% vs 19.4%; p=0.011).